EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ropivacaine synergizes with sorafenib to induce apoptosis of hepatocellular carcinoma cells via the IL ‐6/ STAT3 pathway

Wenting Wang, Hongyun Lin, Desheng Liu, Tao Wang, Zicheng Zhu, Peng Yu iD, Jing Zhang

Cancer Science · 2024

DOI: 10.1111/cas.16261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Wenting Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China. Hauptthemen laut MEDLINE: Ropivacaine, Sorafenib, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of resistance in hepatocellular carcinoma (HCC) cells limits the effectiveness of sorafenib, but combination therapy with other drugs may have a positive effect. However, the effect of ropivacaine combined with sorafenib on the treatment of HCC cells and its potential regulatory mechanisms remain unclear. The proliferation and apoptosis of HCC cells treated with ropivacaine, sorafenib, and ropivacaine plus sorafenib were analyzed by cell‐counting kit 8 and flow cytometry. The protein levels were measured by Western blot. The antitumor effect of ropivacaine, sorafenib, and their combination was verified by a tumor xenograft model. Ropivacaine and sorafenib markedly impeded the viability of HCC cells in a concentration‐dependent manner. Compared with ropivacaine or sorafenib treatment alone, ropivacaine and sorafenib combination treatment impeded HCC cell proliferation, facilitated apoptosis, enhanced cleaved caspase‐3, cleaved caspase‐9, and cyclin D1 protein expression, while it reduced IL‐6 and p‐STAT3 expression and inhibited tumor growth in vivo. Importantly, the activation of the IL‐6/STAT3 pathway could reverse the repressive or stimulative effects of ropivacaine and sorafenib on the proliferation and apoptosis in HCC cells. In summary, ropivacaine synergistically induces sorafenib‐stimulated apoptosis of HCC cells via the IL‐6/STAT3 pathway. Ropivacaine is a potential drug for the treatment of HCC when combined with sorafenib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RopivacaineSorafenibCarcinoma, HepatocellularLiver NeoplasmsSTAT3 Transcription FactorDrug SynergismApoptosisInterleukin-6Xenograft Model Antitumor AssaysCell ProliferationSignal TransductionHumansAnimalsMiceCell Line, TumorMice, NudeAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CMale

Stichwörter der Autor:innen

IL‐6/STAT3 pathwayhepatocellular carcinomaropivacainesorafenib

Substanzen

RopivacaineSorafenibSTAT3 Transcription FactorInterleukin-6STAT3 protein, humanIL6 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
  • Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

ORCID-Profile: Peng Yu

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, W., Lin, H., Liu, D., Wang, T., Zhu, Z., Yu, P., & Zhang, J. (2024). Ropivacaine synergizes with sorafenib to induce apoptosis of hepatocellular carcinoma cells via the IL ‐6/ STAT3 pathway. Cancer Science. https://doi.org/10.1111/cas.16261

Vancouver

Wang W, Lin H, Liu D, Wang T, Zhu Z, Yu P, et al. Ropivacaine synergizes with sorafenib to induce apoptosis of hepatocellular carcinoma cells via the IL ‐6/ STAT3 pathway. Cancer Science. 2024. doi:10.1111/cas.16261

BibTeX
@article{Wang2024,
  author = {Wang, Wenting and Lin, Hongyun and Liu, Desheng and Wang, Tao and Zhu, Zicheng and Yu, Peng and Zhang, Jing},
  title = {Ropivacaine synergizes with sorafenib to induce apoptosis of hepatocellular carcinoma cells via the IL ‐6/ STAT3 pathway},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16261}
}
Kostenlos starten →